Bidirectional crosstalk between cancer-associated fibroblasts and tumor immunity: shaping the microenvironment and response to immune checkpoint therapy
{{output}}
Immune checkpoint therapy (ICT) has revolutionized cancer treatment by restoring cytotoxic T-cell activity, yet primary and acquired resistance remain pervasive. Increasing evidence reveals that such resistance is not dictated solely by tumor-intrinsic factors... ...
